Jeff Weisberg, CPA

Strategic Business Advisor to the Board

Jeff began advising Claritas in 2016 after serving as President of ReproSource Diagnostics from 2014 to 2015.  From 1995 to 2009, Jeff was Chief Financial Officer and Senior Vice President of Athena Diagnostics and then appointed General Manager, a position he held from 2009 through 2014. 

Athena Diagnostics is the nation’s leading esoteric neurological testing company.  During his time at Athena, Jeff successfully managed the company through its period of most significant growth, which resulted in his leading the sale of the company to numerous industry leaders, including Thermo Fisher Scientific and more recently, Quest Diagnostics, within which Athena now operates as the Center of Excellence for Neurology.  Jeff continued to run Athena after each of these and other acquisitions and served as a member of the senior management of the parent corporations. 

Prior to joining Athena, Jeff was, from 1985 to 1995, the Chief Financial Officer of Colorgen and prior to that, from 1979 to 1985, held several positions of increasing responsibility with the “Big Eight” accounting firm of Touche Ross, currently known as Deloitte & Touche.  Jeff holds a bachelor’s degree in business from the University of Massachusetts at Amherst, where he graduated summa cum laude.

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.